| Financial Year |
March 31 2023 |
| Monetary Funds |
2,321,083,171.27 |
| Held-for-trading Financial Assets |
354,969,400.00 |
| Notes Receivable |
186,338,764.82 |
| Accounts Receivable |
2,946,919,920.55 |
| Advances to Suppliers |
283,274,104.99 |
| Other Receivables |
292,305,143.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,843,891.96 |
| Inventories |
549,665,255.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
22,840,554.20 |
| Other Current Assets |
234,283,731.52 |
| Total Current Assets |
7,434,762,830.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
122,427,636.00 |
| Investment Properties |
3,442,195.17 |
| Fixed Assetes |
6,411,833,891.76 |
| Under-construction Projects |
221,400,639.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
692,935,053.77 |
| R&D expenses |
-- |
| Goodwill |
724,233,497.71 |
| Long-Term Deferred and Prepaid Expenses |
115,443,543.33 |
| Deferred Income Tax Assets |
103,452,043.56 |
| Other Non-Current Assets |
407,837,028.86 |
| Sub-Total of Non-Current Assets |
8,874,591,615.30 |
| Total Assets |
16,309,354,445.35 |
| Short-Term Loans |
469,330,788.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,805,769.26 |
| Accounts Payable |
1,050,292,962.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
131,805,347.56 |
| Taxes Payable |
91,584,268.08 |
| Interest Payable |
-- |
| Dividend Payable |
22,115,796.70 |
| Other payables |
260,130,556.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
475,708,489.38 |
| Other Current Liabilities |
28,914,100.60 |
| Sub-Total of Current Liabilities |
2,702,019,029.10 |
| Long-term Loans |
3,274,093,116.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
230,175,217.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,180,360.44 |
| Deferred Income Tax Liabilities |
60,123,625.40 |
| Other Non-Current Liabilities |
11,128,692.64 |
| Sub-Total of Non-Current Liabilities |
3,711,362,514.28 |
| Total Liabilities |
6,413,381,543.38 |
| Paid-In Capital(Or Share Stock) |
2,648,922,855.00 |
| Capital Surplus |
2,563,328,961.88 |
| Surplus Reserve |
275,978,227.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,342,734,550.52 |
| Minority Stockholder's Interest |
1,021,461,788.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,874,511,113.85 |
| Owner's Equity（Stockholder's Equity） |
9,895,972,901.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,309,354,445.35 |
